Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Adenocarcinoma × atezolizumab × Clear all

Phase

Status

Unknown 1 Recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 15 Melanoma 5 Triple Negative Breast Neoplasms 4 Small Cell Lung Carcinoma 4 Neoplasms 4 Carcinoma, Renal Cell 4 Carcinoma, Hepatocellular 4 Breast Neoplasms 4 Head and Neck Neoplasms 3 Urinary Bladder Neoplasms 2 Stomach Neoplasms 2 Mesothelioma, Malignant 2 Gastrointestinal Neoplasms 2 Carcinoma, Merkel Cell 2 Uterine Cervical Neoplasms 1 Urologic Neoplasms 1 Small Cell Lung Cancer Recurrent 1 Safety Issues 1 Recurrent Liver Cancer After Liver Transplantation 1 Recurrence 1 Ovarian Neoplasms 1 Neoplasms, Squamous Cell 1 Neoplasm Metastasis 1 Lymphoma 1 Lung Neoplasms 1 Liver Neoplasms 1 Kidney Neoplasms 1 Hodgkin Disease 1 Fallopian Tube Neoplasms 1 Esophageal Neoplasms 1

Interventions

Capecitabine 5 Pemetrexed 4 Docetaxel 4 pembrolizumab 2 icotinib 2 Oxaliplatin 2 Gemcitabine 2 Gefitinib 2 Drug Therapy 2 Chemoradiotherapy 2 sintilimab 1 rucaparib 1 regorafenib 1 lenvatinib 1 iron isomaltoside 1000 1 ipatasertib 1 iopromide 1 gluconic acid 1 atezolizumab 1 anlotinib 1 XELOX 1 Trastuzumab 1 Telemedicine 1 Surveys and Questionnaires 1 Sorafenib 1 S 1 (combination) 1 Registries 1 Ramucirumab 1 Radiotherapy 1 Radiation 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04739202 2021-03-29

IMMUNOGAST

Hospices Civils de Lyon

Phase 2 Unknown

Gastrointestinal

Adenocarcinoma, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡